What are the side effects of Mobocertinib?

On September 15, 2021, the Food and Drug Administration approved accelerated approval of mobotinib for adult patients with locally advanced or metastatic non-small cell lung cancer. Patients have epidermal growth factor receptor (EGFR) exon 20 insertion mutations, as detected by an FDA-approved test, and their disease has progressed during or after platinum-based chemotherapy.

Mobocertinib/Mobocertinib(Mobocertinib)What are the side effects?

Mobocertinib/Mobocertinib(Mobocertinib) Common side effects includediarrhea (92%), rash (78%), red blood cell decrease (59%), increased creatinine (52%), lymphopenia (52%), stomatitis (46%), increased amylase (40%), vomiting (40%), Decreased appetite(39%), paronychia(39%), nausea(37%), increased lipase(35%), musculoskeletal pain (34%), Dry skin (32%), Fatigue (29%), Reduced potassium (29%), Thrombocytopenia (26%), Decreased leukocytes(25%), increased alkaline phosphatase(25%), itching(24%), cough(24%), decreased albumin(23%), magnesium content decreased(23%), alanine aminotransferase increased(22%), weight loss(21%), ASTincreased(21%), sodium loss(20%), hair loss(19%), abdominal pain(18%), upper respiratory tract infection(16%),Gastroesophageal reflux disease(15%), Difficulty breathing(15%), Runny nose(13%), Indigestion(11%), Eye toxicity(11%), Diarrhea(22%), pan>Lymphopenia(15%), Amylase increase(13%), QTcProlongation(10%), Hypertension(10%)Headache(10%), etc. The price of generic drugs is favorable, ranging from 3 to 4 more than 1,000 per box. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to help you learn more about high-quality overseas drugs.